Chamberlain Healthcare Public Relations

What Chamberlain Healthcare Public Relations does

Chamberlain Healthcare Public Relations is a specialized B2B professional services firm that provides public relations and strategic communications support to pharmaceutical and biotechnology companies. The firm translates complex scientific and medical information into compelling narratives for media, healthcare providers, consumers, and regulators, with stated expertise spanning Oncology, CNS, Dermatology, Rare disease, and Diabetes therapeutic areas. According to firmographic data, the firm was founded in 1993 and operates as a wholly-owned portfolio agency within Syneos Health Communications, the communications arm of the larger Syneos Health organization.

The firm delivers services including media relations, communications strategy, and campaign execution in support of drug approvals and product launches. The company claims to have executed 35+ approvals/launches in the last three years and points to a series of "firsts," including communications support for the first ALS treatment in over 20 years, the first 3D-printed pill in epilepsy, the first auto-injector to reverse opioid overdose, and the first treatment for postpartum depression. Chamberlain operates from offices in New York (headquarters at 200 Vesey Street) and London (10 Bloomsbury Way), serving clients across the Americas and Europe.

Chamberlain's business model is professional services revenue earned through retainer-based engagements and project fees scoped to client needs. Go-to-market is direct enterprise sales targeting pharma and biotech buyers, with no publicly disclosed pricing. The firm is led by Managing Director Arwen Evans and Executive Vice President Chris Montemurro, and has 11-50 employees according to firmographic records. The firm was named one of PRWeek's Best Places to Work for 2025.

Name

Chamberlain Healthcare Public Relations

Legal name

Chamberlain, a Syneos Health company

Website

https://chamberlainpr.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

11–50 employees

Short description

Chamberlain Healthcare Public Relations is a specialized healthcare-focused PR agency that translates complex medical science into compelling narratives for pharmaceutical and biotechnology clients across therapeutic areas including Oncology, CNS, and Rare disease.

Ownership category

akta.pro rank

Product category

Healthcare Public Relations

NAICS

Public Relations Agencies (541820), Advertising, Public Relations, and Related Services (5418), Media Representatives (54184)

akta.pro primary industry

Healthcare & Life Sciences PR (BPAFADAJ)

akta.pro secondary industries

Healthcare & Life Sciences PR (MPAAADAD), Media Relations & Press Office Services (BPAFADAF)

Keywords

• Healthcare public relations
• Pharmaceutical communications
• Medical communications strategy
• Biotech media relations
• Drug launch communications

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Technology or R&D, Others

Revenue model

1. Healthcare PR and Communications Services: Professional services revenue generated through public relations, communications strategy, and media relations engagements serving pharmaceutical and biotech clients. Revenue is derived from retainer-based contracts and project fees for healthcare communications campaigns, media outreach, and strategic counsel.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Chamberlain Healthcare Public Relations is a healthcare-focused public relations agency that translates complex scientific and medical information into compelling, actionable narratives for pharmaceutical and biotechnology clients. The firm provides strategic communications counsel, media relations, and campaign execution in support of drug approvals, product launches, and public awareness efforts across Oncology, CNS, Dermatology, Rare disease, and Diabetes therapeutic areas. Engagements are custom-scoped, retainer- or project-based, and delivered by dedicated account teams via direct enterprise relationships.

Product overview

Chamberlain Healthcare Public Relations is a specialized healthcare communications agency that translates scientific information into meaningful stories for healthcare audiences. Operating as part of Syneos Health Communications, the agency provides public relations services across multiple therapeutic areas including Oncology, CNS, Dermatology, Rare disease, and Diabetes. The agency is recognized for its expertise in launching innovative healthcare treatments and claims to have executed 35+ approvals/launches in the last three years. Key differentiators include their track record of being first to market with multiple treatment innovations across various therapeutic categories.

Differentiator

Problem solved

Functional benefit

Products and services

• Healthcare Public Relations Services Strategic PR and communications services for pharmaceutical and biotechnology clients, translating complex scientific and medical information into compelling narratives that support brand awareness, stakeholder engagement, and public discourse.
• Drug Approval and Launch Communications Communications strategy and execution for FDA approval milestones and product launches, including media relations, stakeholder messaging, and public awareness campaigns to support new therapeutic treatments.
• Therapeutic Area Communications Specialized communications support across Oncology, CNS, Dermatology, Rare disease, and Diabetes therapeutic areas, providing deep domain expertise for highly specialized medical communications needs.

Quantifiable outcome

• 35+ approvals/launches successfully executed in the last three years
• +5 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Syneos Health CommunicationsflagshipStrategic or Co-development PartnerChamberlain Healthcare PR is a purpose-built portfolio agency within Syneos Health Communications, operating as part of a network of health-first, health-only advertising, branding, medical communications, market access, and public relations agencies. Powered by 25,000 clinical and commercial minds across Syneos Health, the organization operates at the intersection of health, technology, and creativity.

Scale indicators2 records

Direct peers

• Real Chemistry: Real Chemistry (formerly W2O Group) is a large, healthcare-focused communications and data analytics firm serving pharma and biotech clients with PR, medical communications, and brand work. It is one of the most direct competitors to Chamberlain's healthcare PR offering, operating at greater scale across overlapping therapeutic areas.
• GCI Health: GCI Health is a global healthcare-focused public relations agency and part of WPP. It competes directly with Chamberlain for pharma and biotech PR mandates, including product launches, disease awareness, and corporate communications across similar therapeutic categories.
• Spectrum Science: Spectrum Science is an integrated healthcare communications agency offering PR, medical affairs, and scientific communications to pharma and biotech clients. It is a head-to-head competitor for Chamberlain's launch communications and therapeutic-area PR work.
• TogoRun: TogoRun is a healthcare-focused PR and communications agency serving pharmaceutical, biotech, and medical device clients. It competes with Chamberlain on product launches, FDA milestones, and disease awareness campaigns in similar therapeutic areas.
• JPA Health: JPA Health is a fully integrated healthcare marketing and communications agency offering PR, advocacy, and digital services. It is comparable to Chamberlain as a mid-sized, healthcare-only competitor for pharmaceutical and biotech launch communications.

Broad incumbents

• Edelman: Edelman operates the largest global PR network with a substantial dedicated Health practice. It competes for healthcare launch mandates as part of a much broader corporate, consumer, and technology portfolio, often winning accounts that would also fit Chamberlain's specialty.
• Weber Shandwick: Weber Shandwick is a global PR leader with a sizeable healthcare practice serving pharma, biotech, and medtech clients. It overlaps with Chamberlain on health-focused product launches and corporate communications as part of a broader communications portfolio.
• Finn Partners: Finn Partners is a global integrated marketing and communications firm with a dedicated Health practice. It competes for healthcare PR engagements from pharma and biotech clients, with capabilities extending well beyond Chamberlain's narrower PR focus.
• Ruder Finn: Ruder Finn is a global communications firm with a long-standing healthcare and life sciences practice. It serves many of the same pharmaceutical and biotech clients as Chamberlain on product launches, corporate reputation, and disease awareness work.

Others

• Syneos Health Communications (sister agencies): Syneos Health Communications operates a portfolio of health-only agencies covering advertising, branding, medical communications, market access, and PR. Chamberlain's sister agencies (e.g., for medical communications and market access) are adjacent ecosystem players that both compete and co-sell with Chamberlain within the same parent network.

Market position

Strengths4 records

Weaknesses4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/ChamberlainHealthcarePR
• LinkedInlinkedin.com/company/chamberlain-healthcare-public-relations
• Instagraminstagram.com/chamberlain_healthcare_pr/?hl=en
• Xx.com/inventivPR

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Chamberlain Healthcare Public Relations